Search
Cancel
Platform
Therapeutics
ioCells™
ioCells™
Discover ioCells
ioCells
ioWild Type Cells
ioDisease Model Cells
Custom cell development
ioWild Type Cells
Nerve cells
ioGABAergic Neurons
ioGlutamatergic Neurons
ioSensory Neurons
Immune cells
ioMicroglia
Muscle cells
ioSkeletal Myocytes
ioDisease Model Cells
Huntington's disease
ioGlutamatergic Neurons HTT 50CAG/WT
FTD and ALS
ioGlutamatergic Neurons MAPT N279K/WT
ioGlutamatergic Neurons MAPT P301S/WT
ioGlutamatergic Neurons MAPT P301S/P301S
ioGlutamatergic Neurons TDP-43 M337V/WT
ioGlutamatergic Neurons TDP-43 M337V/M337V
Parkinson's and Gaucher disease
ioGlutamatergic Neurons GBA null/WT
ioGlutamatergic Neurons PRKN R275W/WT
ioGlutamatergic Neurons PRKN R275W/R275W
Duchenne muscular dystrophy
ioSkeletal Myocytes DMD Exon 44 Deletion
ioSkeletal Myocytes DMD Exon 52 Deletion
News and Events
News and Events
News
View all
Topics
Article
CEO views
Podcast
Press release
New product
News
Talk
Events
View all
Resources
Resources
Resources
View all
General resources
Application notes
bits of bio
Infographics
Posters
Publications
Talks
Videos
Video tutorials
Webinars
Product information
Brochures
User manuals
Protocol library
View all
Browse protocols
ioMicroglia cell detachment
ioMicroglia cytokine release
Blog
View all articles
Browse topics
CEO views
Culture
Expert opinion
Leadership
Science
Technology
Sustainability
About
About
Our company
About us
Leadership and Boards
Sustainability
Work with us
Partners
Careers
Careers
Working at bit.bio
Open roles
Employee spotlights
Contact
Search
Rewriting the story
of human health —
one cell at a time
Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells
Cell identity coding platform
Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.
Explore our platform
Therapeutics
Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.
Learn more
ioCells™
Precision reprogrammed human iPSC-derived cells for research and drug discovery.
Discover ioCells
Latest news
Press Release
bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery
23.05.2023
Published by bit.bio
Read now
New product
Early access product launch for ioSensory Neurons
18.05.2023
Published by bit.bio
Read now
Press Release
Weslie Janeway - investor, scientist, philanthropist joins bit.bio Board
11.05.2023
Published by bit.bio
Read now
Press Release
Collaborating with Mekonos to advance non-viral cell engineering
04.05.2023
Published by Mekonos
Read now